Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma

A TLR9 agonist in combination with a PD-1 inhibitor produced powerful antitumor responses in a clinical trial despite TLR9 agonists as monotherapies failing to generate systemic antitumor immune responses due to immunosuppressive effects. However, the mechanism involved in the improved response indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Binghai, Yan, Jiuliang, Guo, Lei, Zhang, Bo, Liu, Shuang, Yu, Mincheng, Chen, Zheng, Zhang, Kewei, Zhang, Wentao, Li, Xiaoqiang, Xu, Yongfeng, Xiao, Yongsheng, Zhou, Jian, Fan, Jia, Hung, Mien-Chie, Li, Hui, Ye, Qinghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255037/
https://www.ncbi.nlm.nih.gov/pubmed/32483468
http://dx.doi.org/10.7150/thno.44417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255037/
https://www.ncbi.nlm.nih.gov/pubmed/32483468
http://dx.doi.org/10.7150/thno.44417

Ejemplares similares